KATHERINE CRAMPTON: Open Payments
NPI 1285181065 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 27 payments from 15 companies in 2025. Trend: 2023 $466 · 2024 $1,134 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $52 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| PFIZER INC. | 2 | $37 |
| Dexcom, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Novo Nordisk Inc | 2 | $27 |
| Abbott Laboratories | 1 | $23 |
Products named: TRINTELLIX, XIFAXAN, INSPIRE, EVENITY, Dexcom G6 Transmitter, BREZTRI, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
